Publication date: September 2026 Source: Clinical Infection in Practice, Volume 32, Supplement Author(s): Uzair Akbar Ali, Saaz Sahani, Amna Ahsan, Muhammad Shehbaz, Muhammad Wasif Irshad
A multi-centre quality improvement initiative evaluating diagnostic and therapeutic pathways for malaria. // Clinical Infection in Practice. – URL: https://www.sciencedirect.com/science/article/pii/S2590170226001743?dgcid=rss_sd_all
A multi-centre quality improvement initiative evaluating diagnostic and therapeutic pathways for malaria. Clinical Infection in Practice. https://www.sciencedirect.com/science/article/pii/S2590170226001743?dgcid=rss_sd_all
“A multi-centre quality improvement initiative evaluating diagnostic and therapeutic pathways for malaria.” Clinical Infection in Practice.
@article{article41047,
title = {A multi-centre quality improvement initiative evaluating diagnostic and therapeutic pathways for malaria},
journal = {Clinical Infection in Practice},
url = {https://www.sciencedirect.com/science/article/pii/S2590170226001743?dgcid=rss_sd_all}
}
ABSTRACT Background Aspergillus fumigatus can cause life‐threatening infections, primarily treated with azole antifungals. Azole‐resistant A. fumigatus (ARAF) is a major clinical concern. Environmental resistance development is an...
ABSTRACT Background The lipid‐dependent yeast genus Malassezia is composed of skin commensals that can become pathogenic. This genus can cause bloodstream infection in low‐weight preterm neonates and immunocompromised adults. However,...